Home

Today, the MAPRx Coalition and 28 of its members, national organizations representing patients, caregivers, and healthcare professionals, submitted a letter to the Senate Finance Committee on their recently released legislation, The 2019 Prescription Drug Pricing Reduction Act of 2019. The Coalition greatly appreciates the Committee's leadership in improving access to prescription drugs for the more than 44 million Americans who rely on Medicare Part... Read more

On June 6, MAPRx and 45 national advocacy organizations submitted a letter to leadership in the House of Representatives' Ways and Means Committee and Energy and Commerce Committee with recommendations for improving Medicare Part D. Among other improvements, the letter made clear that the MAPRx Coalition supports a cap on out-of-pocket spending for the more than 44 million Americans who depend on... Read more

Today MAPRx submitted comments on behalf of the Coalition and 23 member organizations in support of the Department of Health and Human Services’ proposed rule to reform the rebate system in Medicare Part D in an effort to lower out-of-pocket costs for Part D beneficiaries. The Coalition has long recognized that for the more than 43 million Americans on Part D, high out-of-pocket... Read more

32 MAPRx Members Urge CMS to Take Care in Reforming Critical Prescription Drug Benefit Today MAPRx submitted comments on behalf of the Coalition and 32 member organizations to the Centers for Medicare and Medicaid Services' (CMS) proposed rule entitled Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses which was published in the Federal Register on... Read more

Study Finds Popular Prescription Drug Benefit Program Poses Significant Challenges to Beneficiaries

A new report released today on Medicare Part D found the program is as popular and robust as ever, but poses significant challenges to beneficiaries that result in increased out-of-pocket costs and limited access for millions of beneficiaries. The study, “Navigating Medicare Part D: Approaches to Addressing... Read more

In an op-ed published in The Hill on October 10, Carl Schmid, deputy executive director of MAPRx member organization The AIDS Institute, wrote about the challenges and opportunities facing Medicare Part D. While highlighting the popularity of the prescription drug benefit with nearly 44 million enrolled beneficiaries, Carl also notes that out-of-pocket costs for beneficiaries continue to rise and have... Read more